The Justice Department’s move to end the inquiry into the Fed chair, Jerome Powell, reflected the political reality that ...

GSK's antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, has hit the mark in two phase 3 trials and will be filed for approval as a potential first-in-class treatment for the disease.

The FDA has launched a programme to make it easier for drug companies to set up manufacturing facilities in the US and reduce the country's reliance on imported medicines. Today, the regulator ...

Xcell Therapeutics Inc. is powering standardization in the manufacturing of cell and gene therapies (CGTs) by creating consistent, regulatory-ready, next-generation, chemically defined (CD) ...